Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development

Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development

Abstract Tumor microparticles (T-MPs) are considered as a tumor vaccine candidate. Although some studies have analyzed the mechanism of T-MPs as tumor vaccine, we still lack understanding of how T-MPs stimulate a strong anti-tumor immune response. Here, we show that T-MPs induce macrophages to relea...

Full description

Bibliographic Details
Main Authors: Weiwei Sun, Lili Dai, Yuqing Cao, Pengtao Pan, Lijuan Zhi, Xinke Wang, Xinzhong Yuan, Zi Gao, Sheng Guo, Guoyan Liu, Junlei Yin, Liangliang Xie, Liping Wang, Yanling Wang, Wensheng Li, Hong Li, Yunjie Jia
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Cancer Nanotechnology
Subjects:
Tumor microparticles
Monocytes
Monocyte-derived DCs
IRF4
Tumor vaccine
Online Access:https://doi.org/10.1186/s12645-023-00190-x

Internet

https://doi.org/10.1186/s12645-023-00190-x

Similar Items